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Sarcopenia and Osteoporosis in Hong Kong Chinese Geriatric Hip
Fracture Patient.
W.H.A. Ho, M.L. Lee, W.C. Chan, M.Y. Ng, C.W. Lee, W.S. Ng,
S.H. Wong,
Caritas Medical Centre, Hong Kong, Hong Kong
Introduction: Sarcopenia and osteoporosis are age-related declines
in the quantity of muscle and bone respectively. Both contribute in
disability, fall and hip fracture in elderly.
Methods: We included all geriatric primary hip fracture patients
admitted to Kowloon West Cluster Orthopaedic Rehabilitation
Centre. Hand grip strength and body composition measurement using
Dual-energy x-ray absorptiometry (DEXA) were performed.
Results: There were 356 patients with mean age 81.7. By stratifying in
male and female, the mean hand grip strength were 20.8 and 13.7 kg,
the mean Relative Skeletal Muscle Mass Index (RASM) were 5.79 and
4.90kg/m2, the hip bone mineral density (BMD) were 0.699 and
0.992g/cm2. The prevalence of sarcopenia based on RASM according
to the Asian Working Group for Sarcopenia (AWGS) definition were
89.5% inmale and 76% in female. The prevalence of femoral neck osteo-
porosis basedonhipT-score less than2.5were43.4%inmale and63.6%
in female. RASM was positively correlated with hand grip strength,
body weight, femur T score, hip BMD, body mass index (BMI) and total
fat mass in both male and female. All were statistically significant.
Conclusion: The prevalence of sarcopenia was very high in geriatric hip
fracture patients, and much higher than community dwelling elderly.
Apart from the need to prescribe osteoporosis medicine in geriatric hip
fracture patients, sarcopenia screening and treatment should be addressed,
which is essential to reduce subsequent fall, subsequent fracture and the
fracture-related complications and economic burden to Hong Kong.
0004
Incidence and Risk Factors of Subsequent Hip Fractures in
Korea:Multicenter Study
Kee Haeng Lee 1, Ju Young Kim 2, Soo Jae Yim 3, Do Hyun Moon 4,
Geun Hong Choi 5, Kyoung Ho Moon 5,
1 Bucheon St. Mary's Hospital, Bucheon, Republic of Korea 2 Incheon
St. Mary's Hospital, Incheon, Republic of Korea 3 Buchoen
Soonchunhyang University Hospital, Bucheon, Republic of Korea
4 Gachon University Hospital, Incheon, Republic of Korea 5 Inha
University Hospital, Incheon, Republic of Korea
This study analyzes the incidence of subsequent hip fractures and its
risk factors in the northwestern region of Korea. We analyzed hipfracture patients who visited any of the 5 teaching hospitals in the
Bucheon and Incheon area from January 2000 to December 2010.
Medical records were reviewed and presence of subsequent hip frac-
tures, alcohol history, marital status, live in solitude, dementia, diz-
ziness, American society of anesthesiologists score, osteoporosis
treatment after fracture, body mass index (BMI) and initial bone
mineral density were analyzed. The average follow-up period was
12 months (range 1e130 months). A total of 2,546 patients (women
1,770, men 776) who had experienced hip fractures were included.
Of these, subsequent hip fractures were found in 233 patients (9.2%)
(women 187, men 46). Mean age at the time of the first fracture was
79.2 yr old (range 50e100 yr). The average interval between the
first fracture and the subsequent hip fractures was 30.2 months
(range 4 dayse154 months). In this large-scale, retrospective, multi-
center study, overall incidence of subsequent hip fractures is 9.2%.
Independent risk factors of subsequent fracture are women,
BMI < 22 kg/m2, and being unmarried.
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Clinical and Biochemical Characteristics of Subjects with Diabetes
Suffering from Low Bone Mass and Prevalent Fragility Fracture
Y.C. Woo 1, C.H.N. Loong 1, C.H.Y. Fong 2, V.W.K. Chau 2,
E.L.Y. Leung 1, A.C.H. Lee 1, C.H. Lee 1, M.M.Y. Yuen 1,
J.K.Y. Lam 1, K.C.B. Tan 2,
1 Department of Medicine, Queen Mary Hospital, Hong Kong, Hong
Kong 2 Department of Medicine, the University of Hong Kong, Hong
Kong, Hong Kong
Objective(s): Patients with low bone mass and history of low trauma
fractures are at increased risk of future fracture. Type 2 diabetes is
itself a risk factor for fracture as well. The aim of this study is to eval-
uate the clinical and biochemical characteristics of subjects with low
bone mass and prevalent fragility fracture, who also suffer from type
2 diabetes, in comparison to those without diabetes.
Material and Methods: All patients referred for management of low
bone mass underwent a standardized systematic assessment protocol
with detailed medical history and comprehensive biochemical meas-
urements performed. All patients had their bone mineral density
(BMD) measured by DXA (Dual-energy X-ray Absorptiometry)
scan. Patients with known history of diabetes assessed from 2008
to 2014 were recruited for analysis (DM group). Age- and gender-
matched subjects without diabetes were selected as control (Non-
DM group). The variables were compared between groups by one-
way ANOVA for continuous data and Chi-square test for categorical
data whichever appropriate.
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female) and 502 age- and gender- matched control (age 74.5± 7.8
years, 81.7% female) were included in this report. Comparing to
non-DM control, DM patients had higher BMI (23.5± 3.8 vs.
22.5± 3.6 kg/m2, P< 0.001), fasting glucose (7.20± 2.37 vs.
5.28± 0.72 mmol/L, p< 0.001) and a higher BMD at spine
(0.783± 0.179 vs. 0.716± 0.155 g/cm2, p< 0.001) and at neck of
femur (0.539± 0.123 vs. 0.516± 0.118 g/cm2, p¼ 0.018). The para-
thyroid hormone levels of the two groups were comparable. There
was no difference in history of fall observed in the two groups
(57.7% vs. 49.3%, p¼ 0.283). Fewer subjects in the DM group expe-
rienced back pain (45.9% vs. 55.8%, p¼ 0.011) and their daily cal-
cium intake were significantly lower than the non-DM control
subjects [545.09 (interquartile range (IQR): 202.25-887.93) vs.
600.00 (IQR: 181.93-1018.07) mg/day, p¼ 0.035].
Conclusion(s): For subjects with low bone mass, those with diabetes
present with fracture despite having a higher BMD. They have a
lower dietary calcium intake which may reflect a deficiency in the
general knowledge on bone health. As they are less likely to suffer
from low back pain, their awareness and alertness to the risk of frac-
ture may even be lower. Hence, subjects with diabetes should be
reminded to have adequate dietary calcium during their diabetes diet-
ary education sessions. In addition, fracture risk assessment, as well
as BMD measurement in indicated cases, should also be considered
in diabetes complication screening program.
0006
Bone Density in Patients with Cervical Cancer or Endometrial Cancer
in comparison with Healthy Control; According to the stages
Heungyeol Kim, Kosin University, Busan, Republic of Korea
Objective: To evaluate the bone mineral density (BMD)in the lumbar
spine and femur in postmenopausal women with cervical cancer and
endometrial cancer without bone metastasis in comparison with that
in healthy control postmenopausal women, and to assess the loss of
BMD according to the cancer stage.
Materials and methods: We analyzed the BMD of the lumbar spine
and femur using dual-energy X-ray absorptiometry (DXA) in 218
patients with cervical cancer, 85 patients with endometrial cancer,
and 259 healthy controls. The serum levels of calcium (Ca), phos-
phorus (P), osteocalcin (OSC), and total alkaline phosphatase
(ALP), and urine deoxypyridinoline(DPL) were measured in all
participants.
Results: Age, body mass index, parity, and time since menopause
were not significantly different between the three groups. Serum
Ca level was higher in the cervical cancer group (p¼ 0.000), how-
ever, urine DPL was lower in endometrial cancer group
(p¼ 0.000). The T-scores of basal BMD at the second and fourth
lumbar vertebra (L2, L4) were significantly lower in patients with
cervical cancer (p¼ 0.038, 0.000, respectively) compared to those
in the healthy control groups. Additionally, the incidence of osteopo-
rosis and osteopenia basal status of bone mass was significantly
higher in patients with cervical cancer compared to that in controls
(p¼ 0.016). No differences in basal BMD of the lumbar spine and
femur were observed between patients with cervical cancer accord-
ing to their stages.
Conclusion: Our results suggest that postmenopausal women with
cervical cancer have a lower BMD and are at increased risk of
osteoporosis in the lumbar spine before receiving anticancer treat-
ment compared with postmenopausal women with endometrial can-
cer.0007
Bone Mineral Density of Lumbar Spine and Femur in Patients with
Gynaecologic Cancer
Heungyeol Kim, Kosin University, Busan, Republic of Korea
Objective: To compare the bone mineral density (BMD) of the lum-
bar spine and femur in postmenopausal women with cervical and
endometrial cancer without bone metastasis with that in normal con-
trol postmenopausal women
Methods: we retrospectively analysed the BMD of the lumbar spine
and femur using dual-energy X-ray absorptiometry in 130 patients
with cervical cancer, 68 patients with endometrial cancer, and 225
healthy controls.
Results:The serum levels of calcium, phosphorus, osteocalcin, and
total alkaline phosphatase, and urine deoxypyridinoline were meas-
ured in all participants. Age, BMI, parity, and time since menopause
were not significantly different between the three groups. The T-
scores of basal BMD at the fourth lumbar vertebra (L4) were signifi-
cantly lower in patients with cervical cancer (0.68 ± 0.10) com-
pared to those in the other two groups. Additionally, the incidence
of osteoporosis at L4 according to the basal status of bone mass
was significantly higher in patients with cervical cancer (10.0%)
compared to that in controls (0.4%). Urine deoxypyridinoline levels
were significantly higher in patients with cervical cancer compared
to those in controls. No differences in basal BMD of the lumbar
spine and femur were observed between patients with endometrial
cancer and controls, and no significant differences in biochemical
markers were detected between patients with endometrial cancer
and controls.
Conclusion: Our results suggest that postmenopausal women with
cervical cancer have a lower BMD and are at increased risk of osteo-
porosis in the lumbar spine before receiving anticancer treatment
compared with postmenopausal women with endometrial cancer.0010
The Effect of Femur Neck BMD on the Discriminative characteristics
of FRAX Model of 3 East Asian Countries in Korean Elderly Female
Patient
Kwang-Jun Oh, Yong-Bong Ko, Department of Orthopaedics
Surgery, KonKuk University Medical Center, Seoul, Republic of
Korea
Objectives: There are ongoing concern about the effect of femur
neck BMD on the discrimination of risk for osteoporotic fracture
using FRAX® algorithm, especially in elderly population In this ret-
rospective study, using Korean female patients over 70-year, the
effect of existence of femur neck BMD data on discriminative char-
acteristics of fracture probability of different FRAX model of east
Asian countries (Korea, Japan and China) which have similar ethnic-
ity was assessed.
Methods: The probability for major and hip osteoporotic fracture in
one hundred seven Korean female patients over 70-year (avr.
78.0± 5.0) which were calculated using FRAX model of 3 countries
were analyses depending on the existence of femur neck BMD data
Results: Regardless of femur neck BMD data, the calculated proba-
bility for major and hip osteoporotic fracture using Japan FRAX
was significant higher than those of Korean and China FRAX
(p< 0.05) And there were no significant difference of all fracture
risk calculated by Japan FRAX between those with and without femur
neck BMD data.
